Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-06-16

Clinical Trial Update: Switching to Duloxetine to Ameliorate SSRI-Induced Sexual Dysfunction [Phase 4]

View source ↗

Summary

Phase 4 trial investigating switching to duloxetine to alleviate SSRI-induced sexual dysfunction in individuals with depression; the study was terminated and re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Duloxetine (Cymbalta) (Duloxetine)

Snippet

Sponsor: Stanford University | Conditions: Depression | Phase 4 | Status: TERMINATED | Results posted: 2015-06-16